Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study.
Roest LH, Kosse LJ, van Lint JA, Gosselt HR, Scholl JHG, van Puijenbroek E, Vonkeman HE, Tas SW, Nurmohamed MT, van den Bemt BJF, Jessurun NT. Roest LH, et al. Among authors: nurmohamed mt. Expert Opin Drug Saf. 2023 Mar;22(3):203-211. doi: 10.1080/14740338.2022.2115479. Epub 2022 Aug 28. Expert Opin Drug Saf. 2023. PMID: 36036179
Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
Maracle CX, Agca R, Helder B, Meeuwsen JAL, Niessen HWM, Biessen EAL, de Winther MPJ, de Jager SCA, Nurmohamed MT, Tas SW. Maracle CX, et al. Among authors: nurmohamed mt. Atherosclerosis. 2018 Mar;270:33-41. doi: 10.1016/j.atherosclerosis.2018.01.032. Epub 2018 Jan 31. Atherosclerosis. 2018. PMID: 29407886 Free article.
Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence.
van Heuckelum M, Linn AJ, Vandeberg L, Hebing RCF, van Dijk L, Vervloet M, Flendrie M, Nurmohamed MT, van Dulmen S, van den Bemt BJF, van den Ende CHM. van Heuckelum M, et al. Among authors: nurmohamed mt. PLoS One. 2019 Aug 30;14(8):e0221290. doi: 10.1371/journal.pone.0221290. eCollection 2019. PLoS One. 2019. PMID: 31469852 Free PMC article.
Are Health Care Professionals' Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?
van Heuckelum M, Hebing RCF, Vandeberg L, Linn AJ, Flendrie M, Nurmohamed MT, van Dulmen S, van den Ende CHM, van den Bemt BJF. van Heuckelum M, et al. Among authors: nurmohamed mt. Arthritis Care Res (Hoboken). 2021 Mar;73(3):364-373. doi: 10.1002/acr.24186. Arthritis Care Res (Hoboken). 2021. PMID: 32166901
Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases.
Kosse LJ, Jessurun NT, Vonkeman HE, Tas SW, Nurmohamed MT, Hoentjen F, van Doorn MBA, van Puijenbroek EP, van den Bemt BJF, de Vries M. Kosse LJ, et al. Among authors: nurmohamed mt. Expert Opin Drug Saf. 2020 Nov;19(11):1521-1528. doi: 10.1080/14740338.2020.1803826. Epub 2020 Aug 12. Expert Opin Drug Saf. 2020. PMID: 32730115
Perspective of patients with autoimmune diseases on COVID-19 vaccination.
Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J, Nurmohamed MT, Boers M, Kuijpers TW, van Ham SM, Eftimov F, Wieske L, Rispens T, Wolbink GJ. Boekel L, et al. Among authors: nurmohamed mt. Lancet Rheumatol. 2021 Apr;3(4):e241-e243. doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22. Lancet Rheumatol. 2021. PMID: 33655220 Free PMC article. No abstract available.
401 results